Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Keywords

MedicineHemostasisIntensive care medicineClinical trialVariety (cybernetics)Function (biology)ThrombosisSurgeryPathologyComputer science

Affiliated Institutions

Related Publications

Functional hemodynamic monitoring.

Michael R. Pinsky , Didier Payen

Hemodynamic monitoring is a central component of intensive care. Patterns of hemodynamic variables often suggest cardiogenic, hypovolemic, obstructive, or distributive (septic) ...

2005 Critical Care 356 citations

Publication Info

Year: 2005
Type: article
Volume: 3
Issue: 4
Pages: 692-694
Citations: 4695
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

4695

OpenAlex

Cite This

APA Style

                            
                                    Sam Schulman, 
                                
                                    Clive Kearon
                                
                            (2005). 
                            Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients. 
                            Journal of Thrombosis and Haemostasis
                            , 3
                            (4)
                            , 692-694.
                            https://doi.org/10.1111/j.1538-7836.2005.01204.x

Identifiers

DOI: 10.1111/j.1538-7836.2005.01204.x